Group | Treatment1 |
---|---|
1 (Control) | PBS nose drops, 300 μL/per mouse |
2 (Infection) | H9N2 AIV nose drops, 300 μL/per mouse |
3 (Neongreen) | PBS nose drops, 300 μL/per mouse; intragastrical administration oflabeled bacteriaat 3 dpi, 300 μL/per mouse |
4 (Infected-Neongreen) | H9N2 AIV nose drops, 300 μL/per mouse; intragastrical administration oflabeled bacteriaat 3 dpi, 300 μL/per mouse |
5 (Ageratum-liquid) | PBS nose drops, 300 μL/per mouse; filled with ALat 2, 3, 4 dpi, 1 mL/100 g, perday |
6 (Infection-Ageratum-liquid) | H9N2 AIV nose drops, 300 μL/per mouse; filled with ALat 2, 3, 4 dpi, 1 mL/100 g, perday |
7 (Ageratum-liquid-Neongreen) | PBS nose drops, 300 μL/per mouse; filled with ALat 2, 3, 4 dpi, 1 mL/100 g, perday; intragastrical administration oflabeled bacteria at 3 dpi, 300 μL/per mouse |
8 (Infection-Ageratum-liquid-Neongreen) | H9N2 AIV nose drops, 300 μL/per mouse; filled with ALat 2, 3, 4 dpi, 1 mL/100 g, perday; intragastrical administration oflabeled bacteria at 3 dpi, 300 μL/per mouse |